{"title":"Curcumin as a Multifaceted Epigenetic Modulator With a Disease-Oriented Perspective.","authors":"Hedieh Sadat Shamsnia, Mahtab Roustaei, Amirreza Peyrovinasab, Mazyar Ataei, Fatemeh Shafiean, Mohammadmahdi Ghavamipour Komleh, Mobina Tajdari, Mohammad Mahdi Khosravi Nia, Sayna Sadeghi Kivi, Amir Hossein Abdolghaffari","doi":"10.1002/ptr.70401","DOIUrl":null,"url":null,"abstract":"<p><p>Curcumin (diferuloylmethane), a polyphenolic compound, is a component of Curcuma longa , commonly known as turmeric. It is well known for its therapeutic properties in a variety of diseases. One of its distinctive mechanisms is epigenetic modification. Epigenetic changes involve alterations in DNA methylation, histone modifications, and non-coding RNA expression patterns, which are interconnected and play a crucial role in various pathologies. It has been shown that curcumin inhibits DNA methyltransferases (DNMT), thereby reversing abnormal hypermethylation and reactivating silenced genes. Concurrently, it downregulates histone deacetylases (HDACs), promotes histone acetyltransferase (HAT) activity, and modulates the expression of non-coding RNAs, including miRNAs. Consequently, curcumin regulates many mechanisms, including inflammatory cascades, oxidative stress responses, and neuronal function. Curcumin's broad-spectrum activity has been demonstrated in various pathologies. For instance, in cancer, it modulates epigenetic mechanisms to support tumor suppression; in neurodegenerative diseases, it enhances neuronal survival; and in metabolic disorders, it improves insulin responsiveness. It also reduces inflammation and fibrosis in cardiovascular, hepatic, renal, and inflammatory conditions. This review will describe curcumin's diverse role as an epigenetic modulator from a novel disease-oriented perspective.</p>","PeriodicalId":20110,"journal":{"name":"Phytotherapy Research","volume":" ","pages":"5639-5671"},"PeriodicalIF":8.1000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytotherapy Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ptr.70401","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Curcumin (diferuloylmethane), a polyphenolic compound, is a component of Curcuma longa , commonly known as turmeric. It is well known for its therapeutic properties in a variety of diseases. One of its distinctive mechanisms is epigenetic modification. Epigenetic changes involve alterations in DNA methylation, histone modifications, and non-coding RNA expression patterns, which are interconnected and play a crucial role in various pathologies. It has been shown that curcumin inhibits DNA methyltransferases (DNMT), thereby reversing abnormal hypermethylation and reactivating silenced genes. Concurrently, it downregulates histone deacetylases (HDACs), promotes histone acetyltransferase (HAT) activity, and modulates the expression of non-coding RNAs, including miRNAs. Consequently, curcumin regulates many mechanisms, including inflammatory cascades, oxidative stress responses, and neuronal function. Curcumin's broad-spectrum activity has been demonstrated in various pathologies. For instance, in cancer, it modulates epigenetic mechanisms to support tumor suppression; in neurodegenerative diseases, it enhances neuronal survival; and in metabolic disorders, it improves insulin responsiveness. It also reduces inflammation and fibrosis in cardiovascular, hepatic, renal, and inflammatory conditions. This review will describe curcumin's diverse role as an epigenetic modulator from a novel disease-oriented perspective.
期刊介绍:
Phytotherapy Research is an internationally recognized pharmacological journal that serves as a trailblazing resource for biochemists, pharmacologists, and toxicologists. We strive to disseminate groundbreaking research on medicinal plants, pushing the boundaries of knowledge and understanding in this field.
Our primary focus areas encompass pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine. We actively encourage submissions on the effects of commonly consumed food ingredients and standardized plant extracts. We welcome a range of contributions including original research papers, review articles, and letters.
By providing a platform for the latest developments and discoveries in phytotherapy, we aim to support the advancement of scientific knowledge and contribute to the improvement of modern medicine.